| Role |
Name |
Disclosure |
Details |
| Author | Belen Carsi, MD, PhD, FRCS, Consultant, Department of Orthopedics, St. Helens and Knowsley NHS Trust | Nothing to disclose | Details | | Coauthor | Franklin Sim, MD, Chairman of Orthopedic Oncology, Professor, Department of Orthopedic Surgery, Mayo Medical School | Nothing to disclose | Details | | Medical Editor | Sanjiv S Agarwala, MD, Chief of Oncology and Hematology, St Luke's Cancer Center, St Luke's Hospital and Health Network; Associate Professor of Cancer Biology, University of Pennsylvania | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Benjamin Movsas, MD, Vice-Chairman, Department of Radiation Oncology, Fox Chase Cancer Center | Nothing to disclose | Details | | CME Editor | Rajalaxmi McKenna, MD, FACP, Consulting Staff, Department of Medicine, Southwest Medical Consultants, SC, Good Samaritan Hospital, Advocate Health Systems | Nothing to disclose | Details | | Chief Editor | Jules E Harris, MD, Clinical Professor of Medicine, Division of Hematology/Medical Oncology, Department of Internal Medicine, University of Arizona College of Medicine at Tucson; Consulting Staff, Arizona Cancer Center | GlobeImmune Amplimed | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Franklin Sim, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Sanjiv S Agarwala, Medical Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Benjamin Movsas, Managing Editor |
The contributor discloses no conflict of interest. |
|